🔎 Trials Near Me

Home › Heart Valve Diseases › NCT04073420

Medtronic Cardiac Surgery PMCF Registry

RecruitingObservational study

Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry

Who can join

All ages · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
2. Patient has or is intended to receive or be treated with an eligible product
3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment

Exclusion Criteria:

1. Patient who is, or is expected to be, inaccessible for follow-up
2. Patient prohibited from participation by local law
3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results

About the study

This registry is being conducted to support ongoing post-market surveillance activities.

What is being tested

Sponsor: Medtronic Cardiac Surgery · Participants: 2,700 · Started: Dec 2, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT04073420

Locations in the U.S.

GeorgiaWellStar Kennestone Hospital, Marietta
MichiganUniversity of Michigan, Ann Arbor
New YorkMount Sinai Medical Center, New York
Saint Josephs Hospital Health Center, Syracuse
North CarolinaDuke University Medical Center, Durham
OhioUniversity Hospitals Cleveland, Cleveland
PennsylvaniaUniversity of Pittsburgh Medical Center UPMC Presbyterian, Pittsburgh
TexasBaylor St. Luke's Medical Center, Houston
The Heart Hospital Plano, Plano
VirginiaInova, Falls Church

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.